BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8918487)

  • 1. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
    Balmaceda C; Heller G; Rosenblum M; Diez B; Villablanca JG; Kellie S; Maher P; Vlamis V; Walker RW; Leibel S; Finlay JL
    J Clin Oncol; 1996 Nov; 14(11):2908-15. PubMed ID: 8918487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors.
    Buckner JC; Peethambaram PP; Smithson WA; Groover RV; Schomberg PJ; Kimmel DW; Raffel C; O'Fallon JR; Neglia J; Shaw EG
    J Clin Oncol; 1999 Mar; 17(3):933-40. PubMed ID: 10071287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    Pediatr Blood Cancer; 2004 Aug; 43(2):126-33. PubMed ID: 15236278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
    Tscherry G; Jacky E; Jost LM; Stahel RA
    Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for relapsed CNS germinoma after primary chemotherapy.
    Merchant TE; Davis BJ; Sheldon JM; Leibel SA
    J Clin Oncol; 1998 Jan; 16(1):204-9. PubMed ID: 9440744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
    Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
    J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
    Heideman RL; Kovnar EH; Kellie SJ; Douglass EC; Gajjar AJ; Walter AW; Langston JA; Jenkins JJ; Li Y; Greenwald C
    J Clin Oncol; 1995 Sep; 13(9):2247-54. PubMed ID: 7666082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
    J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
    Kretschmar C; Kleinberg L; Greenberg M; Burger P; Holmes E; Wharam M
    Pediatr Blood Cancer; 2007 Mar; 48(3):285-91. PubMed ID: 16598761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma.
    Sawamura Y; Shirato H; Ikeda J; Tada M; Ishii N; Kato T; Abe H; Fujieda K
    J Neurosurg; 1998 Jan; 88(1):66-72. PubMed ID: 9420074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    de Rezende ACP; Weltman E; Chen MJ; Helito JK; de Carvalho ÍT; Sakuraba RK; Silva NS; Cappellano AM; Hamerschlak N
    PLoS One; 2019; 14(12):e0226350. PubMed ID: 31860688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.
    Motzer RJ; Mazumdar M; Bosl GJ; Bajorin DF; Amsterdam A; Vlamis V
    J Clin Oncol; 1996 Apr; 14(4):1098-105. PubMed ID: 8648363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
    Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
    J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
    Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
    Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
    Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.